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IT has been noted in the past by various workers that the amount of infective
virus obtainable from extracts of Rous No. 1 sarcomata varies from 0 to approxi-
mately 107 infective doses per gramme of tissue and is dependent on such factors
as the rate of growth of the tumour, the age of the host bearing the tumour, and
the age ofthe tumour itself (Carr, 1943, 1953; Duran-Reynals and Freire, 1953).
Provided that the extracts are made from tumours of approximately the same
age, the influence of antibody on virus yield can be kept within fairly constant
limits and the effect ofrate ofgrowth and host age can be studied. So far, there
have been no reports in the literature ofa correlation between the actual quantities
of virus material present in tumour extracts and the infectivity of such extracts.
The experiments to be described were therefore designed to investigate any pos-
sible relationship between these two factors.
MATERIALS AND METHODS.
Chickens from Dr. Greenwood's Edinburgh flock provided the animal material
used throughout this work.
Virus andparticulate preparations.
The Rous No. 1 sarcoma virus and the particulate fraction of the cytoplasm
corresponding to the virus in size and general chemical properties were isolated
by the fractional centrifugation method of Carr and Harris (1951), a diagram of
which is shown in Fig. 1. The tissues were first homogenized in an M.S.E. Atomix
homogenizer, or ground with sand, or macerated in small glass macerators and the
cells lysed in ten volumes of distilled water. In the case of the tumour tissue,
the procedure was standardized and only the small glass macerators were used.
The Servall Angle centrifuge Type SS.1 employing lusteroid tubes was used for
isolating the particulate fractions of the cytoplasm. After treatment with hyal-
uronidase for halfan hour to reduce the high viscosity, the extracts were clarified
by centrifugation for 15 minutes at 3000 r.p.m. (1000 x g.). The supernatant
(Sj) containing virus and some coarser cytoplasmic constituents and aggregates
was then centrifuged at 12,000 r.p.m. for 55 minutes (16,000 x g.). The pellets
which resulted (D2) were taken up in the same number of ml. water as there were
grams of original tissue and treated with crystalline trypsin in M/5 sodium phos-
phate solution for 1 hour at 370 C. The resuspended pellet before treatment
with trypsin is designated D2A. After incubation with trypsin the suspension isAMOUNT OF VIRUS MATERIAL AND INFECTIVITY
called D2B. The suspension was clarified after enzyme treatment by centri-
fuging at 3000 r.p.m. for 15 minutes and, finally, the supernatant (SO) was centri-
fuged further at 12,000 r.p.m. for 55 minutes. The pellet obtained (D4) was
taken up in a convenient known quantity ofdistilled water for protein estimation
by the biuret method described below, or for nitrogen estimation by the micro-
Kjeldahl method.
Hyaluronidase treated
10 per cent tumour homogenate
16,000
D2A = Resuspended deposit before trypsin
treatment (w/v tumour tissue).
D2B = Deposit after trypsin treatment
1 hour at 370C.
16,000
= rejected.
" purified " virus concentrate.
FIG. 1.
Infectivity titrations.
A small quantity of S3 was removed for this purpose. Serial tenfold dilutions
were made in saline and inoculated into young chicks in 0-2 ml. amounts according
to the method of Carr and Harris (1951).
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Biuret methodfor quantitative estimation ofparticles.
The method was essentially that described by Stickland (1951) for the deter-
mination of small quantities of bacteria, but with two modifications. Firstly,
the single biuret reagent ofWeichselbaum (1946) was used as being more conven-
ient and accurate than separate additions of alkali and copper sulphate. This
reagent keeps well and gives with protein a stable colour which is linear within
the limits 0.004-0.140 g. protein per 100 ml. biuret complex.
The second modification was necessary because of the high proportion of
lipid associated with the particulates (about 50 per cent). This remains in suspen-
sion after development of the colour and interferes with the absorption reading.
After various methods were tried, it was found that the simplest means ofremov-
ing the lipoid material was to shake with ether, centrifuge and pipette off the
fluffy layer of fatty material which came to the surface. A correction of 8 per
cent must be added to the absorptiometer reading of solutions treated in this way
due to the solubility of ether in water. The standardized procedure for deter-
mining protein by the biuret method was therefore as follows: One ml. of the
suspension in a suitable amount of water to keep the concentration of protein
within the required limits, was added to a 1 x 7*5 cm. test tube. One ml. of the
biuret reagent was then added and the contents of the tube mixed. Colour was
developed by heating in a 31-32° C. water bath for 30 minutes. The solution
was then cooled and if it showed turbidity, one ml. ether was added and the tube
shaken vigorously for a minute.. After centrifuging in an angle head for 30 min-
utes at 2500 r.p.m., the lipid could be removed with a micro-pipette. The solu-
tion was finally read in the Spekker absorptiometer using the 0-5 ml. micro cells
and the yellow-green filter. A blank reading was obtained by mixing 1 ml. of
the biuret reagent with 1 ml. distilled water. The amount of protein could then
be estimated by referring to a standard curve of known amounts of protein, or,
when it was required to know the total amount of particulate or virus material,
this could be read directly from a standard curve made by measuring the absorp-
tion of known amounts of dried particulate or virus material, In this way, a
large number ofdeterminations could be made quickly and easily with a reliability
of about ± 2 per cent.
EXPERIMENTAL.
(1) Application of the biuret reaction to the measurement ofvirus protein.
Since the biuret reaction seemed to offer a convenient method for following
the protein distribution ofthe various fractions during the isolation of the " puri-
fied " virus concentrate, it was necessary to determine how much of the protein
in the particles took part in the colour reaction. To do this, samples of pure
virus or particulate protein were prepared by dissolving the defatted particles
in a minimum amount of NaOH and precipitating the protein by the addition of
..n equal volume of 10 per cent trichloracetic acid. The precipitated protein was
washed once with water and used for total nitrogen determinations by the micro-
Kjeldahl method and for " biuret " protein determinations. The various pre-
parations gave similar results and an average value for the Spekker absorptio-
meter reading given by 1 mg. cell particulate protein was 0-167 compared with
0'150 for fowl serum protein. It was found that the biuret colour intensity was
linear for amounts of protein less than 3*0 mg. per 2*0 ml. of biuret complex.
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When estimating quantities of whole particulates in the " purified " fractions,
a linear colour relationship existed for amounts corresponding to 0 05 to 5-25
mg. dry weight particulates per 2-0 ml. biuret complex.
Next, various preparations of cell particulates from normal fowl tissues and a
non filterable fowl sarcoma (GRCH/16, Peacock and Peacock, 1953) and purified
virus from Rous No. 1 sarcoma were subjected to (1) total nitrogen determina-
tions by the micro-Kjeldahl method, (2) dry weight and (3) biuret protein deter-
minations in order to estimate the ratio
"Directly estimated protein nitrogen":
"Total nitrogen
" (Table I).
TABLE I.-Dry Weight, Total Nitrogen and Biuret Protein of Cell Particu-
lates Deposited from Normal and Malignant Fowl Tissues by Centri-
fuging at 12,000 r.p.m. for 55 minutes.
Biuret
Dry wt. Total N protein Total N Protein Protein N
mg./g. mg.!g. mg./g. Dry wt. Dry wt. Total N
Source. wet tissue. wet tissue. wet tissue. (%). (%). (%).
Rous No.
1Sarcoma 0 43
. 0037 . 0-198 5-6 . 46 . 85
0-095 0°49 * 82 ,, ** . ~~~~~~~0- 090 .0-41 ..-.73
GRCH/16
. 4-10 0340
. 1-68 8- 3 . 41 . 79
Liver
. . 2340
. 2-32 1-20 99 48 77
Spleen
. 5-10
. 0-414 . 1-99 8-1 39 . 78
Brain 2-94 0-241
. 1-15 . 8-2 . 39 76
Averages 8-6 . 43±4 . 79±4
* Not referred back to original weight of tissue used. Figures indicate mg./ml. suspension.
The values of Total N: Dry weight give an average value of 8.6 per cent which
agrees with the findings ofother workers (Claude, 1938; Shemin and Sproule, 1942).
The value of 79 per cent for the ratio protein N: Total N seems reasonable. It
is not known exactly how much of the nitrogen in these particles can be attri-
buted to protein since the amounts of nucleic acid are not accurately known.
Claude (1939) estimated that 10-15 per cent ofthe protein fraction of Rous sarcoma
virus (5-8 per cent of the total virus material) was nucleic acid using u.v. absorp-
tion methods, whereas Shemin and Sproule (1942), basing their estimation on
purine nitrogen values, gave approximately 1-5 per cent of total virus material as
nucleic acid. By using these values for nucleic acid and assuming lipid to be
50 per cent of the total material (with a nitrogen content of 1-6 per cent) it can be
easily calculated that the protein nitrogen constitutes between 76 per cent and
87 per cent of the total N. The value of 79 per cent found in the foregoing experi-
ments lies between the calculated figures and it thus seems that most, if not all
the particulate and virus protein enters into the biuret reaction.
(2) Protein distribution during virus purification procedure.
The biuret method was used, therefore, to follow the protein distribution
during the purification of the Rous sarcoma virus. At the same time, the virus
activity of each fraction was determined by titration in day old chicks. In one
experiment 26-5 g. of fresh tumour tissue were processed accordinrg to the diagram
shown in Fig. 1 and the results of the experiment are given in Table II.
All the fractions were tested for activity except D2B (second deposit after
trypsin digestion). There is usually some aggregated material present in this
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TABLE II.-Protein Distribution at each each Stage of the Extraction of
26.5g. Rous Sarcoma Tissue.
Dilution
Mg. necessary
protein in Protein as for tumour Mg. Mg. protein
26-5 g. % total production protein required for
Fraction. tumour. protein. x 0-2 c.c. in 0-2 c.c. infection.
S1 . . . 460
S2 . . . 430 . 94 . 10-4 . 33 3.3x1O-5
D2A . 38 . 8-3 . 10-5 *38 .3 - 8 X 10-
D2B (trypsin) . 33 . 7-2
83 . . . 26 . 56 . 10-5 *20 .2 - 0 x10-6
D3 . . . 4- 2 . *91 10-2 *13 . 13x10-3
S4 . . . 14-6 . 3-2 . 0-3 . *11 . 1I x10-4
D4 . . . 6-3 . 1-4 . 10-5 *02 . 2-0x10-7
fraction which does not form a stable suspension and any attempt to titrate it
gives rise to unreliable results. The figures in Column 1 of Table II are direct
measurements of protein and some discrepancies in the amounts at each stage
are unavoidable but the final column shows that the virus concentrate, D4, pro-
vides the inaximum infectivity with the least amount of protein. 2-0 X 10-7
g. compares favourably with the results of other workers. Treatment with the
enzyme trypsin has removed 19-6 mg. " biuret " protein from 38 mg. in D2A
(52 per cent) which is close to the value of 60 per cent found by Carr and Harris
(1951). It is also apparent that the final virus concentrate (D4) contains approxi-
mately 1-4 per cent of the protein in the original extract yet retains most of the
infectivity. This, again, agrees closely with results using nitrogen estimations.
(3) Effect of trypsin treatment on the microscopic appearance of extracts of Rous
No. 1 sarcoma.
Samples of the partially purified extracts at Stages D2A, D2B and S3 (Fig. 1)
were examined in the dark field microscope in order to ensure that the " purified "
virus concentrate was free from non particulate material. The examination
showed that D2A (resuspended deposit from first high speed run) consisted of
fairly coarse aggregates, some filaments and large spheres and many smaller
particulates. D2B (same after trypsin treatment) contained a larger proportion
of small particulates and few filaments or large spheres. S3 (after clarification
at 3000 r.p.m.) showed a homogenous suspension of fine particulates with very
few of the larger bodies present.
(4) Virus particle estimation and infectivity titrations for Rous No. 1 sarcomata
growing in hosts of various ages.
The chickens were inoculated with a 10 per cent suspension of Rous sarcoma
cells (0.5 ml.) in both pectoral muscles and the size ofthe tumours was determined
by palpation. All extractions were made of tumours between 12 and 28 days of
age and usually between 14 and 21 days. The + sign method for estimating
size was used, + being just palpable, ++ covering one quarter of the breast,
+++ onehalfand ++++ the entire breast. For convenience, only two groups
have been used in the table of results, (Table III) slow growing tumours being
considered as all those less than +++ in size at the time of extraction. The
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virus particle measurements and infectivity titrations were done by the methods
described in the first part of the paper.
The results include 35 extractions and cover a wide range ofinfectivity values.
The final column in Tables III and IV (virus yields) represent the dry weight of
whole virus particles (including the lipoid portion) as determined by the biuret
TABLE III.-" Purified" Virus Content and Infectivity Titres ofFast
and Slow Growing Rous No. 1 Sarcomatafrom Hosts of Various Ages.
Infectivity (M.I.D./g. wet tumour).
Fast growing. Slow growing.
107
105
106
105
105 -
106
104
106
JC6
105
104
103
- 104
105
105
106
106
106
103
103
105
105
105
<102
<102
105 -
105
>104
>104
<-102
104
105
104
105
<10
Average
"Purified " virus
content mg./g.
wet tumour.
.49
.37
*25
.33
*24
.43
-52
*60
.43
*28
*36
.45
70
.34
*27
*31
*28
*51
*36
*56
*36
*38
*52
*38
.59
*40
*29
*38
.34
.43
*88
.44
*52
*68
.43
*46±-14
* The extracts from these two birds were not diluted sufficiently to reach a true end point, but it
was apparent from the latent period of the tumours appearing in the chicks treated with the 10-4
dilution that at least a further 1/10 dilution would have produced a response.
t This bird developed a " recurring tumour " (Carr, 1942) which appeared 150 days after the
original inoculation in a chicken of the " Non-susceptible " strain.
TABLE IV.-Average Virus Concentrate Yields arranged in order of
Increasing Virus Infectivity.
M.I.D./g.
tumour.
103 or less
104 and 105
108 and over .
" Purified "
No. of virus yield and
observations. standard deviation.
7 . 464 -09
20 . *434*16
8 . *41± 12
Age of host
(days).
22
28
32
51
56
57
57
58
65
66
66
70
72
73
78
78
82
84
87
91
105
108
115
143
143
161
161
192*
213*
213
442
446
447
454
253t
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procedure. The recent experiment of Duran-Reynals and Freire (1953) in which
tumours growing in old hosts exhibited a larger number ofnon-infective filtrates is
borne out in this workby the fact that the onlynon-infective extraots encountered
occurred in hosts over 140 days old (Table III). The data also include five pairs of
chickens which can be compared as regards infectivity of slow and fast growing
tumours of the same age. The members of each pair came from the same hatch
and were inoculated at the same time with similar amounts of Rous cell sus-
pensions. In every case the slow growing tumour contained less infective virus
than the fast growing one although the average yields of virus material were
almost identical, namely 0 43 mg./g. from fast growing and 0*46 mg./g. from slow
growing tumours. The observations of Carr (1953) that slow growing tumours
contain less infective virus than fast growing ones are, therefore, confirmed in this
series. In Table IV, the results are arranged in groups of increasing infectivity.
Analysis of variance showed that there was no significant difference between the
"purified " virus yields of any of the groups at the 5 per cent level or 10 per
cent level although the infective capacity ofthe preparations ranged from 0 to 107
minimum infective doses (M.I.D.) per g. of tumour tissue.
DISCUSSION.
The preliminary experiments show that it is possible to adapt the biuret
reaction for proteins to the quantitative estimation of cytoplasmic particles and
viruses provided the large proportion of fat associated with them is removed by
shaking with ether or by some similar procedure. This technique should prove
useful under a variety of conditions as it is fairly certain that all of the protein
in the particles is involved in the reaction. The fact that the biuret method
yields similar results to those obtained with the micro-Kjeldahl nitrogen proce-
dure when applied to the distribution of protein during purification of Rous sar-
coma virus shows that the method, though more quickly and easily done, yields
reliable results. It is apparent from the figures in Tables III and IV that, within
the limits of the experimental conditions, no very marked differences in the
amounts of" purified " virus material could be detected despite the wide variation
in infectivity. This is in agreement with the observations of Eckert et al (1952)
on the virus particle content of the plasma of birds with erythromyeloblastic
leukosis. These authors could find no correlation between the infectivity, num-
ber of primitive cells, or the number of virus particles deposited by ultra centri-
fugation and counted directly in the electron microscope.
Such observations, ofcourse, raise the question ofthe purityofthe preparations
used. In the present work, the method of virus purification is one which has
been selected as giving the highest activity with the least expenditure of time so
that virus will not be lost through oxidation and excessive handling. Since it
has been shown that concentrated tumour extracts are almost completely agglu-
tinated by fowl virus-neutralizing antibody (Amies, 1937) and that anti-fowl
protein precipitins were only present in very low concentrations in the sera of
rabbits sensitized to tumour virus particles (Amies and Carr, 1939) it seems reason-
able to assume that the " purified "virus concentrates are related to Rous sarcoma
tissue and foreign to fowl tissue. Such studies as these combined with the fact
that the agent behaves as a single, homogeneous substance electrophoretically
(Shemin and Sproule, 1942) seem to indicate that the large number of particles
necessary for infoction is due to most ofthe material being composed of" inactive
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virus and bring the results for the Rous agent into line with other viruses. If
the mass ofa Rous virus particle is taken as 32x 10-l6g. (calculatedfor a sphere
ofradius 4
0 x 10-6 cm. and a density of 1.3), then the extracts employed here
contain approximately 1-4 x 1012 particles per gram of tumour tissue. The most
active tumour yielded 107 infective doses/g., therefore the number of particles re-
quired toinitiate a tumour response in thiscase was ofthe order of100,000. Claude
(1939) and Claude and Rothen (1942) using similar techniques were able to prepare
an extract in which only about 2000 particles were necessary for infection, but
such differences may be due to variation in the chicken strains. The work of
Eckert et al. (1952), already mentioned, has shown that in erythromyeloblastic
leukosis, the infectivity of the plasmas exhibited a range of at least five log1o
increments, while the numbers of particles only varied from 0-1 x 109 to 7.2 x
109 per ml. Bryan (1941) showed that for Shope papilloma virus, 9 4 x 107
particles were necessary for a 50 per cent infectious unit. Both of these viruses
show evidence of existence in a
"masked
" form, as does Rous No.1 agent.
The production of large amounts of non-infective material is not confined to
tumour viruses alone, and has been observed in other types, whether plant, animal
or bacterial. Bawden and Pirie (1946) estimated that at least 107 particles of
tobacco mosiac virus were necessary to provide an infective dose and were able to
separate their preparations into fractions with different infectivities. Gard and
von Magnus (1946) showed that large doses of influenza virus cause the cells lining
the allantoic cavity of eggs to produce non-infective agglutinin and Doermann
(1951) demonstrated the multiplication of T2 bacteriophages in a non-infective
form by releasing them at various times during their growth cycle. These and
many other observations lead to the conclusion that infectivity is one of the final
properties with which a virus particle becomes endowed. The nature of the
tumour virus growth cycle, which, after the initial infection, remains entirely
intracellular, probably favours the very large production of non-infective material
which has been observed in these experiments.
It would appear then, that, any changes in the virus must be of quality rather
than quantity, i.e., an alteration of the proportions of infective to non-infective
virus. That the non-infective material is still capable of causing tumour growth
is apparent from the many observations on
"masked virus " which shows no
infectivity but which later becomes capable of infecting when the tumour is trans-
planted to new hosts. It is possible that the ratio, infective: non-infective virus
may give rise to larger variations in infectivity than would be expected from
simply a larger proportion of the infective phase, due to the phenomenon of inter-
ference alreadynoted in some animal and plant viruses and bacteriophages (Henle,
1950; Luria and Delbruck, 1942 ; Kleczkowski and Kleczkowski, 1953,; Bawden
and Kleczkowski, 1953), In the case of Rous No. 1 sarcoma the most important
factors influencing the ratio of the two phases seems to be reflected in the rate of
growth of the tumour and the age of the host. While it is true that the infec-
tivity of Rous No.
1 sarcomata is inversely proportional to the age of the tumour
itself, this effect is caused by an increase in circulating antibodies (Carr, 1943).
The antibodies reduce the amount of infective virus by forming floccules with
virus which are lost during the extraction procedure, and by neutralizing the
virus remaining in suspension. When tumours 12 to 28 days of age are used,
as in this work, the antibodies have little or no effect on the infectivity of the
extracts. The reduced amounts ofinfective virus found in old hosts by Carr (1953)
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while not so strikingly evident in this series ofbirds, would appear to be borne out
by the fact that 107 M.I.D./g. were only encountered once, in a very young host,
and 106 M.I.D./g. were never observed in extracts from hosts over 100 days old.
Old hosts did, however, produce a larger number ofslow growing tumours showing
little or no necrosis and haemorrhage and yielding less infective virus, and the
only tumours yielding non-infective filtrates were found in hosts over 140 days
old.
SUMMARY
1. The biuret reaction for proteins has been adapted for use in making esti-
mates of the yields of cytoplasmic particles, with which virus activity is asso-
ciated, from Rous No. 1 sarcomata. The method gives results comparable to
those obtained with total nitrogen estimations and it is fairly certain that all the
protein contained in the particles is involved in the reaction.
2. Measurements of purified virus yields and virus infectivity of extracts of
35 tumours of different growth rates in hosts of various ages show that although
infectivity varies from 0 to 107 minimum infective doses per g. of tumour, the
virus yields remain fairly constant at 0-46 ± 0-14 mg./g. (1.4 x 1012 particles/g.).
No significant differences appear when the extracts are divided into groups of
low, medium and high infectivity. It is concluded that the differences in infec-
tivity are probably due to qualitative alterations in the ratio, infective: non-
infective virus, rather than a quantitative change.
3. The observations support therecentfinding ofreducedinfectivityintumours
of adult hosts and in slow growing tumours. The reduced occurrence of non-
infective tumours in old hosts has also been confirmed.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign.
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